Paul Tudor Jones Relay Therapeutics, Inc. Transaction History
Tudor Investment Corp Et Al
- $15.5 Billion
- Q1 2024
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 65,441 shares of RLAY stock, worth $426,675. This represents 0.0% of its overall portfolio holdings.
Number of Shares
65,441
Previous 31,314
108.98%
Holding current value
$426,675
Previous $344,000
57.85%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding RLAY
# of Institutions
188Shares Held
127MCall Options Held
4.2KPut Options Held
1.7K-
Sb Investment Advisers (Uk) LTD London, X027.9MShares$182 Million2.29% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$77 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.8MShares$63.9 Million0.0% of portfolio
-
Casdin Capital, LLC New York, NY7.42MShares$48.4 Million4.98% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.88MShares$44.9 Million0.01% of portfolio
About Relay Therapeutics, Inc.
- Ticker RLAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 120,219,000
- Market Cap $784M
- Description
- Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...